DE60004262D1 - Polymorphes salz eines anti-migrainemittels - Google Patents

Polymorphes salz eines anti-migrainemittels

Info

Publication number
DE60004262D1
DE60004262D1 DE60004262T DE60004262T DE60004262D1 DE 60004262 D1 DE60004262 D1 DE 60004262D1 DE 60004262 T DE60004262 T DE 60004262T DE 60004262 T DE60004262 T DE 60004262T DE 60004262 D1 DE60004262 D1 DE 60004262D1
Authority
DE
Germany
Prior art keywords
polymorphes
salt
anti migraine
migraine
polymorphes salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60004262T
Other languages
English (en)
Other versions
DE60004262T2 (de
Inventor
Arthur Bentley
Arnold Howard-Field
James Ogilvie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE60004262D1 publication Critical patent/DE60004262D1/de
Publication of DE60004262T2 publication Critical patent/DE60004262T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60004262T 1999-09-28 2000-09-14 Polymorphes salz eines anti-migrainemittels Expired - Lifetime DE60004262T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9922963 1999-09-28
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (2)

Publication Number Publication Date
DE60004262D1 true DE60004262D1 (de) 2003-09-04
DE60004262T2 DE60004262T2 (de) 2004-01-22

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004262T Expired - Lifetime DE60004262T2 (de) 1999-09-28 2000-09-14 Polymorphes salz eines anti-migrainemittels

Country Status (50)

Country Link
US (1) US6369094B1 (de)
EP (1) EP1233960B1 (de)
JP (1) JP3795395B2 (de)
KR (1) KR100479897B1 (de)
CN (1) CN1155594C (de)
AP (1) AP2004A (de)
AR (1) AR025779A1 (de)
AT (1) ATE246185T1 (de)
AU (1) AU779580B2 (de)
BG (1) BG65161B1 (de)
BR (1) BR0014272A (de)
CA (1) CA2379572C (de)
CO (1) CO5180567A1 (de)
CR (1) CR6561A (de)
CU (1) CU23200A3 (de)
CZ (1) CZ2002971A3 (de)
DE (1) DE60004262T2 (de)
DK (1) DK1233960T3 (de)
DZ (1) DZ3254A1 (de)
EA (1) EA004510B1 (de)
EE (1) EE200200171A (de)
EG (1) EG24143A (de)
ES (1) ES2200911T3 (de)
GB (1) GB9922963D0 (de)
GE (1) GEP20043365B (de)
GT (1) GT200000159A (de)
HK (1) HK1048628B (de)
HR (1) HRP20020270B1 (de)
HU (1) HUP0202821A3 (de)
IL (1) IL147154A (de)
IS (1) IS2162B (de)
MA (1) MA26821A1 (de)
MX (1) MXPA02003311A (de)
MY (1) MY121170A (de)
NO (1) NO321936B1 (de)
NZ (1) NZ516093A (de)
OA (1) OA12024A (de)
PA (1) PA8498901A1 (de)
PE (1) PE20010662A1 (de)
PL (1) PL354960A1 (de)
PT (1) PT1233960E (de)
SI (1) SI1233960T1 (de)
SK (1) SK3982002A3 (de)
TN (1) TNSN00187A1 (de)
TR (1) TR200200804T2 (de)
TW (1) TWI265926B (de)
UA (1) UA72272C2 (de)
WO (1) WO2001023377A2 (de)
YU (1) YU2602A (de)
ZA (1) ZA200202406B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
AU2005311714B2 (en) * 2004-12-03 2010-09-30 Merck Sharp & Dohme Corp. Pharmaceutical composition containing an anti-nucleating agent
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
CA2777937C (en) 2009-10-26 2017-08-29 Merck Sharp & Dohme Corp. Solid pharmaceutical compositions containing an integrase inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
NZ501419A (en) * 1997-07-03 2000-09-29 Pfizer Pharmaceutical compositions containing eletriptan hemisulphate and caffeine for treating migraines, depression and eating disorders

Also Published As

Publication number Publication date
CN1364166A (zh) 2002-08-14
KR100479897B1 (ko) 2005-03-31
CA2379572C (en) 2006-11-14
DE60004262T2 (de) 2004-01-22
KR20020032627A (ko) 2002-05-03
ATE246185T1 (de) 2003-08-15
UA72272C2 (uk) 2005-02-15
BG65161B1 (bg) 2007-04-30
BG106240A (en) 2002-07-31
EE200200171A (et) 2003-06-16
IL147154A0 (en) 2002-08-14
CZ2002971A3 (cs) 2003-04-16
EP1233960B1 (de) 2003-07-30
AP2004A (en) 2009-06-10
BR0014272A (pt) 2002-05-21
ES2200911T3 (es) 2004-03-16
HUP0202821A2 (hu) 2003-01-28
JP3795395B2 (ja) 2006-07-12
NO20021525L (no) 2002-03-26
MXPA02003311A (es) 2002-10-04
NO20021525D0 (no) 2002-03-26
PA8498901A1 (es) 2004-02-07
DK1233960T3 (da) 2003-10-27
AP2002002457A0 (en) 2002-06-30
PE20010662A1 (es) 2001-06-23
US6369094B1 (en) 2002-04-09
MY121170A (en) 2005-12-30
CO5180567A1 (es) 2002-07-30
JP2003510318A (ja) 2003-03-18
GT200000159A (es) 2002-03-20
TR200200804T2 (tr) 2002-07-22
CU23200A3 (es) 2007-04-06
HK1048628B (zh) 2004-10-21
IL147154A (en) 2005-11-20
WO2001023377A9 (en) 2002-03-28
IS2162B (is) 2006-11-15
AR025779A1 (es) 2002-12-11
HUP0202821A3 (en) 2003-12-29
SK3982002A3 (en) 2003-05-02
DZ3254A1 (fr) 2001-04-05
HRP20020270A2 (en) 2003-06-30
AU6721300A (en) 2001-04-30
GB9922963D0 (en) 1999-12-01
EG24143A (en) 2008-08-06
EA200200302A1 (ru) 2002-10-31
AU779580B2 (en) 2005-01-27
CN1155594C (zh) 2004-06-30
YU2602A (sh) 2004-11-25
HRP20020270B1 (en) 2004-04-30
ZA200202406B (en) 2003-05-28
CA2379572A1 (en) 2001-04-05
TNSN00187A1 (fr) 2005-11-10
EA004510B1 (ru) 2004-04-29
OA12024A (en) 2006-04-19
EP1233960A2 (de) 2002-08-28
CR6561A (es) 2005-04-04
GEP20043365B (en) 2004-05-10
TWI265926B (en) 2006-11-11
WO2001023377A3 (en) 2002-03-07
HK1048628A1 (en) 2003-04-11
NO321936B1 (no) 2006-07-24
IS6223A (is) 2002-01-08
WO2001023377A2 (en) 2001-04-05
PT1233960E (pt) 2003-11-28
NZ516093A (en) 2005-01-28
PL354960A1 (en) 2004-03-22
MA26821A1 (fr) 2004-12-20
SI1233960T1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
CY2016002I1 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
NO20014987L (no) Substituerte azoler
DK1163237T3 (da) Amidderivater
DE60020812D1 (de) Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel
MA26816A1 (fr) Derives d'amino-triazolopyridine
IS2209B (is) Nýjar bensóímidasól afleiður nytsamlegar sem andfjölgunar miðlar
EE200300001A (et) Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm
DE60032601D1 (de) Als antikrebsmittel verwendbare heterocyklische derivate
NO20020304D0 (no) Konserverte farmasöytiske preparater
DE60004262D1 (de) Polymorphes salz eines anti-migrainemittels
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
DE60005808D1 (de) Pestizide indazol- oder benzotriazolderivate
PT1153014E (pt) Derivados de beta-alanina
ATE299876T1 (de) Indolderivate
DE60025630D1 (de) Glucopyranosid-konjugate von 2-(4-hydroxy-phenyl)-1-ä4-(2-amin-1-yl-ethoxy)-benzylü-1h-indol-5-olen
IS6434A (is) Nýjar indól afleiður
NO20020306L (no) Indolderivater
DE60045237D1 (de) Approximation des Betrags eines Vektors
EE200100381A (et) Morfolinobensamiidi uued soolad
MA25653A1 (fr) Derives d'amides heterocycliques.
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
DE50003014D1 (de) N-substituierte perhydrodiazine
NO20022682D0 (no) Heterosykliske derivater
DE50010602D1 (de) Regelung eines ottomotors
ATE414059T1 (de) Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition